Samuel Vokurka

1.2k total citations
50 papers, 669 citations indexed

About

Samuel Vokurka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Samuel Vokurka has authored 50 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Samuel Vokurka's work include Lymphoma Diagnosis and Treatment (15 papers), Oral health in cancer treatment (11 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Samuel Vokurka is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Oral health in cancer treatment (11 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Samuel Vokurka collaborates with scholars based in Czechia, United States and Slovakia. Samuel Vokurka's co-authors include Vladimír Koza, Kateřina Steinerová, Michal Karas, Rebecca H. Stone, Alessandra D’Addio, Werner Rabitsch, Matthias Schwenkglenks, Hermann Einsele, Dietger Niederwieser and Ann Roosaar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Neurophysiology.

In The Last Decade

Samuel Vokurka

43 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samuel Vokurka Czechia	14	358	333	218	152	104	50	669
Christopher Fraser Australia	13	218 0.6×	261 0.8×	92 0.4×	49 0.3×	418 4.0×	33	799
D. Elhardt United States	4	441 1.2×	325 1.0×	263 1.2×	23 0.2×	148 1.4×	8	700
Ziad E. Deeb United States	15	180 0.5×	176 0.5×	46 0.2×	101 0.7×	53 0.5×	33	822
C. Frederick LeMaistre United States	5	444 1.2×	351 1.1×	261 1.2×	14 0.1×	157 1.5×	5	702
Samer Al‐Khudari United States	12	124 0.3×	124 0.4×	222 1.0×	20 0.1×	12 0.1×	49	509
Michael Jaglal United States	12	57 0.2×	148 0.4×	30 0.1×	84 0.6×	89 0.9×	78	420
Joseph C. Sniezek United States	15	115 0.3×	344 1.0×	93 0.4×	51 0.3×	7 0.1×	28	871
S.H. Nantel Canada	14	115 0.3×	259 0.8×	7 0.0×	126 0.8×	381 3.7×	22	680
Scott H. Saul United States	20	222 0.6×	224 0.7×	26 0.1×	241 1.6×	14 0.1×	34	1.1k
C. Hennequin France	14	278 0.8×	241 0.7×	31 0.1×	81 0.5×	15 0.1×	72	711

Countries citing papers authored by Samuel Vokurka

Since Specialization

Citations

This map shows the geographic impact of Samuel Vokurka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Vokurka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Vokurka more than expected).

Fields of papers citing papers by Samuel Vokurka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Vokurka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Vokurka. The network helps show where Samuel Vokurka may publish in the future.

Co-authorship network of co-authors of Samuel Vokurka

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Vokurka. A scholar is included among the top collaborators of Samuel Vokurka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Vokurka. Samuel Vokurka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vokurka, Samuel, Andrea Pokorná, Vojtěch Mezera, et al.. (2022). Oncology wounds – recommendations for care based on multidisciplinary cooperation. Klinicka onkologie. 35(5). 408–420. 1 indexed citations

Král, Zdeněk, Heidi Móciková, Jana Marková, et al.. (2019). Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia. Journal of Cancer. 10(21). 5041–5048. 9 indexed citations

Janíková, Andrea, Zbyněk Bortlíček, Vít Campr, et al.. (2018). The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database. Annals of Hematology. 97(4). 669–678. 13 indexed citations

Ferda, Jiří, Samuel Vokurka, Eva Ferdová, et al.. (2018). The application of the prostatic specific membrane antigene ligand <sup>68</sup>Ga-PSMA-11 in imaging of prostatic tumors using PET/CT and PET/MRI - initial experience with tolerance of the applied substance and imaging quality. 72(1). 51–57.

Mírka, Hynek, et al.. (2018). Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging. Anticancer Research. 38(7). 4149–4152. 2 indexed citations

Chanan‐Khan, Asher, Andrey Zaritskey, Miklós Egyed, et al.. (2017). Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Haematology. 4(11). e534–e543. 29 indexed citations

Pytlík, Robert, Heidi Móciková, David Belada, et al.. (2016). Staging and Treatment Response Evaluation in Malignant Lymphomas – Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification). Klinicka onkologie. 29(4). 295–302. 6 indexed citations

Móciková, Heidi, Robert Pytlík, Andrea Janíková, et al.. (2016). Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry. Leukemia & lymphoma. 57(12). 2777–2783. 25 indexed citations

Janíková, Andrea, Zbyněk Bortlíček, Vít Campr, et al.. (2015). Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database. Leukemia & lymphoma. 57(5). 1094–1103. 7 indexed citations

10.

Raber‐Durlacher, Judith E., Samuel Vokurka, Joel B. Epstein, et al.. (2014). Oral Complications in Hematopoietic Stem Cell Recipients: The Role of Inflammation. Mediators of Inflammation. 2014. 1–18. 54 indexed citations

11.

Janíková, Andrea, Zbyněk Bortlíček, Vít Campr, et al.. (2014). Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?. Leukemia & lymphoma. 56(8). 2350–2356. 23 indexed citations

12.

Tonar, Zbyněk, David Šálek, Samuel Vokurka, et al.. (2014). Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(5). 587–597. 10 indexed citations

13.

Janíková, Andrea, Zbyněk Bortlíček, Vít Campr, et al.. (2013). Radiotherapy With Rituximab Is Better than Radiotherapy alone In First Line Treatment Of Localized Follicular Lymphoma. Time To Change a Standard Strategy?. Blood. 122(21). 4388–4388. 3 indexed citations

14.

Vokurka, Samuel, Tomáš Svoboda, Daniel Rajdl, et al.. (2013). Serum citrulline levels as a marker of enterocyte function in patients after allogeneic hematopoietic stem cells transplantation – a pilot study. Medical Science Monitor. 19. 81–85. 12 indexed citations

15.

Dvořák, Pavel, Daniel Lysák, Samuel Vokurka, et al.. (2013). The translocation t(2;11)(p21;q23) without MLL gene rearrangement—a possible marker of good prognosis in myelodysplastic syndrome patients. Hematological Oncology. 32(2). 82–86. 3 indexed citations

16.

Vokurka, Samuel, et al.. (2012). [Angioimmunoblastic T-cell lymphoma as a very poor-prognosis malignancy--a single centre experience].. PubMed. 25(3). 206–11. 1 indexed citations

17.

Pospı́šilová, Dagmar, Jana Čmejlová, Jan Starý, et al.. (2012). The Czech National Diamond-Blackfan Anemia Registry: Clinical data and ribosomal protein mutations update. Blood Cells Molecules and Diseases. 48(4). 209–218. 21 indexed citations

18.

Vokurka, Samuel, et al.. (2011). The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m2 autologous hematopoietic stem cell transplantation. European Journal of Oncology Nursing. 15(5). 508–512. 21 indexed citations

19.

Vokurka, Samuel, Kateřina Steinerová, Michal Karas, & Vladimír Koza. (2009). Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2. Bone Marrow Transplantation. 44(9). 601–605. 42 indexed citations

20.

Vokurka, Samuel, et al.. (2008). Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation. Supportive Care in Cancer. 17(2). 145–151. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact